U.S. Markets close in 5 hrs 52 mins

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
279.21-1.36 (-0.48%)
As of 10:07AM EDT. Market open.
People also watch
Full screen
Previous Close280.57
Bid278.58 x 300
Ask278.82 x 100
Day's Range278.38 - 284.46
52 Week Range223.02 - 333.65
Avg. Volume1,597,764
Market Cap59.64B
PE Ratio (TTM)17.49
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube17 hours ago

    Biogen, Inc. – Value Analysis (NASDAQ:BIIB) : June 22, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Biogen, Inc. a score of 84. Our analysis is based on comparing Biogen, Inc. with the following peers – Amgen Inc., Celgene Corporation, Gilead Sciences, Inc., Johnson & Johnson, AbbVie, Inc., Pfizer Inc., Sanofi Sponsored ADR, Acorda Therapeutics, Inc., Sangamo Therapeutics, Inc. and Bio-Rad Laboratories, Inc. Class ... Read more (Read more...)

  • Futures: These 2 Big Breakouts Highlight New Market Leadership
    Investor's Business Dailyyesterday

    Futures: These 2 Big Breakouts Highlight New Market Leadership

    Nasdaq 100 futures edged higher Thursday morning as Oracle surged on strong earnings. On Wednesday, Celgene broke out as biotechs and business software increasingly lead the market rally.

  • Financial Times2 days ago

    [$$] Pharma recovers composure as price concerns ease

    The Nasdaq Biotechnology Index enjoyed one of its best rallies since the US election on Wednesday, helping a broad rise for the healthcare sector, as investors bet that Donald Trump's administration will ...